Chang Alex C Y, Blau Helen M
Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA; Stanford Cardiovascular Medicine, Stanford University School of Medicine, Stanford, CA, USA.
Baxter Laboratory for Stem Cell Biology, Department of Microbiology and Immunology, Institute for Stem Cell Biology and Regenerative Medicine, Stanford University School of Medicine, Stanford, CA, USA; Stanford Cardiovascular Institute, Stanford University School of Medicine, Stanford, CA, USA.
Differentiation. 2018 Mar-Apr;100:31-36. doi: 10.1016/j.diff.2018.02.001. Epub 2018 Feb 9.
Cardiovascular diseases are the leading cause of death worldwide and the incidence increases with age. Genetic testing has taught us much about the pathogenic pathways that drive heritable cardiomyopathies. Here we discuss an unexpected link between shortened telomeres, a molecular marker of aging, and genetic cardiomyopathy. Positioned at the ends of chromosomes, telomeres are DNA repeats which serve as protective caps that shorten with each cell division in proliferative tissues. Cardiomyocytes are an anomaly, as they are largely non-proliferative post-birth and retain relatively stable telomere lengths throughout life in healthy individuals. However, there is mounting evidence that in disease states, cardiomyocyte telomeres significantly shorten. Moreover, this shortening may play an active role in the development of mitochondrial dysfunction central to the etiology of dilated and hypertrophic cardiomyopathies. Elucidation of the mechanisms that underlie the telomere-mitochondrial signaling axis in the heart will provide fresh insights into our understanding of genetic cardiomyopathies, and could lead to the identification of previously uncharacterized modes of therapeutic intervention.
心血管疾病是全球主要的死亡原因,其发病率随年龄增长而增加。基因检测让我们对导致遗传性心肌病的致病途径有了很多了解。在此,我们讨论衰老的分子标志物——端粒缩短与遗传性心肌病之间出人意料的联系。端粒位于染色体末端,是DNA重复序列,作为保护帽,在增殖组织中随着每次细胞分裂而缩短。心肌细胞是个例外,因为它们在出生后基本不再增殖,在健康个体中一生中端粒长度相对稳定。然而,越来越多的证据表明,在疾病状态下,心肌细胞端粒会显著缩短。此外,这种缩短可能在扩张型和肥厚型心肌病病因核心的线粒体功能障碍发展中起积极作用。阐明心脏中端粒-线粒体信号轴的潜在机制,将为我们理解遗传性心肌病提供新的见解,并可能导致发现以前未被描述的治疗干预模式。